Radiation Therapy in Treating Patients With Liver Metastases

Completed · Phase 1

Conditions studied: Metastatic Cancer

In brief

RATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase I trial is studying the side effects and best dose of radiation therapy in treating patients with liver metastases.

Key facts

Study ID

NCT00255814

Run by

Radiation Therapy Oncology Group

People needed

26

Starts

2005-11-01

Expected to finish

2013-11-01

Last updated by the study team

2015-11-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• James P. Wilmot Cancer Center at University of Rochester Medical Center — Rochester, New York, United States
• Princess Margaret Hospital — Toronto, Ontario, Canada
• McGill Cancer Centre at McGill University — Montreal, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.